The daily dose: October 27, 2021

# Covaxin saga continues: The Technical Advisory Group reviewing Covaxin will reconvene on November 3rd for the final risk-benefit assessment. And thi

Comments

Popular posts from this blog

‘No difference between Congress, PFI’: Karnataka BJP

2 Mangaluru businessmen in Saudi to fly 167 home